Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (62390)	7/15/2019 8:17:10 AM
From: Goose94	Read Replies (1) \| Respond to of 202936

Can'tTrust (TRST-T) the scandal has shaken investor confidence in the weed sector. Canntrust has halted all sales. Health Canada has issued Canntrust a non-compliance order for growing thousands of kilograms of pot in five unlicensed rooms in its 12-room greenhouse in Pelham, ON Canntrust shares finished the week down 48.3 per cent. While the fallout has been dramatic for Canntrust, the implications of Health Canada's investigation are being felt industry-wide. Institutional investors who were warming to the sector are reassessing their interest. Meanwhile, concerns are mounting that Health Canada may respond to the compliance breach by increasing regulatory demands. Canopy Growth (WEED-T), Aurora Cannabis (ACB-T), Horizons Marijuana Life Sciences Index (HMMJ-T) exchange traded fund and other weed related equities lost ground on Friday. Cannabis lawyer Patricia Olasker says events at Canntrust have really shaken people's confidence. She says, "Any lawyer you talk to will say they have a number of deals that could be impacted by this." The Globe says Canntrust was viewed as one of the highest-quality operators in the space.